Variable | pre-treatment | 12 months after treatment | P |
---|---|---|---|
Increased CSF WBC counta | 5/12(42%) | 0/12(0%) | 0.012 |
Increased CSF protein concentrationa | 7/12(58%) | 2/12(17%) | 0.035 |
Four-fold decline in CSF RPR | – | 11/13(85%) | – |
Four-fold decline in serum RPR | – | 6/13(46%) | – |
Median MMSE (IQR) | 13(9.5–15) | 19(16.5–20.5) | < 0.001 |